Atlas Legacy Advisors, LLC

Position in MRK — Merck & Co., Inc.

CIK 2054111 LOS ANGELES, CA

Position in MRK

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$588,272

+$167,979 QoQ

Shares Held

4,578

+31.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#2,554

of 3,769 holders

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 76% Shared 24% None 0%

Healthcare · as of Jun 30, 2026

Atlas Legacy Advisors, LLC holds $5,121,297 across 6 Drug Manufacturers - General names. MRK ranks #5 (11.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,579	$1,893,899
2	JNJ	Johnson & Johnson	4,361	$1,107,562
3	ABBV	AbbVie Inc.	2,607	$656,025
4	AMGN	Amgen Inc	1,644	$595,324
5	MRK	Merck & Co., Inc. This page	4,578	$588,272
6	NVS	Novartis AG	1,788	$280,215

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$588,272	4,578	+31.0%	Shares	Sole	2026-07-31
2026-03-31	$420,293	3,494	-17.5%	Shares	Other	2026-05-11
2025-12-31	$445,669	4,234	+17.8%	Shares	Other	2026-01-29
2025-09-30	$301,728	3,595	+34.2%	Shares	Sole	2025-10-30
2025-06-30	$212,069	2,679	+7.0%	Shares	Sole	2025-08-06
2024-12-31	$249,097	2,504	—	Shares	Sole	2025-01-31
No filing history on record for this holder in this stock.